Brain tumor cells in circulation are enriched for mesenchymal gene expression

Cancer Discovery

Volumn 4, Issue 11, 2014, Pages 1299-1309

  Sullivan, James P ^a,b   Nahed, Brian V ^a,b   Madden, Marissa W ^a   Oliveira, Samantha M ^a   Springer, Simeon ^a   Bhere, Deepak ^b   Chi, Andrew S ^a,b   Wakimoto, Hiroaki ^a,b   Michael Rothenberg, S ^a,b   Sequist, Lecia V ^a,b   Kapur, Ravi ^b   Shah, Khalid ^b   John Iafrate, A ^a,b   Curry, William T ^a,b   Loeffler, Jay S ^a   Batchelor, Tracy T ^a,b   Louis, David N ^a,b   Toner, Mehmet ^b   Maheswaran, Shyamala ^a,b   Haber, Daniel A ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD45 ANTIGEN; DELTA LIKE PROTEIN 3; EPIDERMAL GROWTH FACTOR RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA MULTIFORME 24; GLIOBLASTOMA MULTIFORME 8; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLASMINOGEN ACTIVATOR INHIBITOR 1; POTASSIUM CHLORIDE COTRANSPORTER 2; PROMININ 1; PROTEIN KINASE B BETA; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR MASH1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; TUMOR MARKER;

ANIMAL CELL; ARTICLE; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXPRESSION VECTOR; FLUORESCENCE IMAGING; GENE AMPLIFICATION; GENE EXPRESSION; GENE TRANSLOCATION; GLIOBLASTOMA; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NODULE; LYMPHADENOPATHY; MESENCHYME CELL; MESENCHYMOMA; MOUSE; NONHUMAN; PATIENT DERIVED XENOGRAFT; PRIMARY TUMOR; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; TUMOR BLEEDING; TUMOR NECROSIS; TUMOR XENOGRAFT; VISCERAL METASTASIS; ANIMAL; BLOOD; BRAIN TUMOR; PATHOLOGY; TUMOR EMBOLISM;

ANIMALS; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; MICE; NEOPLASTIC CELLS, CIRCULATING;

EID: 84908406981     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-14-0471     Document Type: Article

References (31)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109.
2. Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA 2013; 310: 1842-50.
3. Smith DR, Hardman JM, Earle KM. Contiguous glioblastoma multiforme and fibrosarcoma with extracranial metastasis. Cancer 1969; 24: 270-6.
4. Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 2003; 3: 453-8.
5. Yu M, Stott S, Toner M, Maheswaran S, Haber DA. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 2011; 192: 373-82.
6. Alix-Panabieres C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA. Annu Rev Med 2012; 63: 199-215.
7. Ozkumur E, Shah AM, Ciciliano JC, Emmink BL, Miyamoto DT, Brachtel E, et al. Inertial focusing for tumor antigen-dependent and-independent sorting of rare circulating tumor cells. Sci Transl Med 2013; 5: 179ra47.
8. Wakimoto H, Mohapatra G, Kanai R, Curry WT Jr, Yip S, Nitta M, et al. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. Neuro Oncol 2012; 14: 132-44.
9. Tchoghandjian A, Baeza N, Colin C, Cayre M, Metellus P, Beclin C, et al. A2B5 cells from human glioblastoma have cancer stem cell properties. Brain Pathol 2010; 20: 211-21.
10. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson M D, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010; 17: 98-110.
11. Grzmil M, Morin P Jr, Lino MM, Merlo A, Frank S, Wang Y, et al. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGFbeta signaling pathway in human glioblastoma. Cancer Res 2011; 71: 2392-402.
12. Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman B A, et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A 2010; 107: 18392-7.
13. Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, et al. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med 2010; 2: 25ra3.
14. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006; 9: 157-73.
15. Colman H, Zhang L, Sulman EP, McDonald JM, Shooshtari NL, Rivera A, et al. A multigene predictor of outcome in glioblastoma. Neuro Oncol 2010; 12: 49-57.
16. Bhat KP, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, et al. Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell 2013; 24: 331-46.
17. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013; 339: 580-4.
18. Dong S, Nutt CL, Betensky RA, Stemmer-Rachamimov AO, Denko NC, Ligon KL, et al. Histology-based expression profiling yields novel prognostic markers in human glioblastoma. J Neuropathol Exp Neurol 2005; 64: 948-55.
19. Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH, et al. Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 2004; 64: 920-7.
20. Brat DJ, Van Meir EG. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 2004; 84: 397-405.
21. Seidel S, Garvalov BK, Wirta V, von Stechow L, Schanzer A, Meletis K, et al. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain 2010; 133: 983-95.
22. Dias-Santagata D, Akhavanfard S, David SS, Vernovsky K, Kuhlmann G, Boisvert SL, et al. Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine. EMBO Mol Med 2010; 2: 146-58.
23. Chi AS, Batchelor TT, Dias-Santagata D, Borger D, Stiles CD, W ang DL, et al. Prospective, high-throughput molecular profiling of human gliomas. J Neuro Oncol 2012; 110: 89-98.
24. Sauka-Spengler T, Bronner-Fraser M. A gene regulatory network orchestrates neural crest formation. Nat Rev Mol Cell Biol 2008; 9: 557-68.
25. Zarkoob H, Taube JH, Singh SK, Mani SA, Kohandel M. Investigating the link between molecular subtypes of glioblastoma, epithelialmesenchymal transition, and CD133 cell surface protein. PLoS ONE 2013; 8: e64169.
26. Tso CL, Freije WA, Day A, Chen Z, Merriman B, Perlina A, et al. Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Res 2006; 66: 159-67.
27. Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 2014; 344: 1396-401.
28. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011; 472: 90-4.
29. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, G ronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-92.
30. Wakimoto H, Kesari S, Farrell CJ, Curry WT Jr, Zaupa C, Aghi M, et al. Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res 2009; 69: 3472-81.
31. Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, Deng G, et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS ONE 2012; 7: e33788.